Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 261

Similar articles for PubMed (Select 25013474)

2.

Expression and clinical significance of the Trop-2 gene in advanced non-small cell lung carcinoma.

Jiang A, Gao X, Zhang D, Zhang L, Lu H.

Oncol Lett. 2013 Aug;6(2):375-380. Epub 2013 May 29.

3.
4.

Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer.

Al-Saad S, Donnem T, Al-Shibli K, Persson M, Bremnes RM, Busund LT.

Anticancer Res. 2009 Oct;29(10):4175-83.

5.

Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.

Sukawa Y, Yamamoto H, Nosho K, Kunimoto H, Suzuki H, Adachi Y, Nakazawa M, Nobuoka T, Kawayama M, Mikami M, Matsuno T, Hasegawa T, Hirata K, Imai K, Shinomura Y.

World J Gastroenterol. 2012 Dec 7;18(45):6577-86. doi: 10.3748/wjg.v18.i45.6577.

6.

[Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].

Liao DW, Wang L, Zhang XG, Liu MQ.

Ai Zheng. 2006 Oct;25(10):1238-42. Chinese.

PMID:
17059767
7.

Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.

Xu XY, Lin N, Li YM, Zhi C, Shen H.

Pathol Res Pract. 2013 Jun;209(6):345-52. doi: 10.1016/j.prp.2013.02.015. Epub 2013 Mar 25.

PMID:
23602236
8.

A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.

Trigka EA, Levidou G, Saetta AA, Chatziandreou I, Tomos P, Thalassinos N, Anastasiou N, Spartalis E, Kavantzas N, Patsouris E, Korkolopoulou P.

Oncol Rep. 2013 Aug;30(2):623-36. doi: 10.3892/or.2013.2512. Epub 2013 May 31.

PMID:
23728071
9.

Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells.

Zito CR, Jilaveanu LB, Anagnostou V, Rimm D, Bepler G, Maira SM, Hackl W, Camp R, Kluger HM, Chao HH.

PLoS One. 2012;7(2):e31331. doi: 10.1371/journal.pone.0031331. Epub 2012 Feb 15.

10.

Prognostic significance of protein kinase B/Akt pathway in patients with non-small cell lung cancer.

Mayadagli A, Karabulut Gul S, Bilici A, Fatih Oruc A, Kocak M, Ozkan A, Aksu A, Ozdemir Barisik N, Gumus M.

J BUON. 2014 Jan-Mar;19(1):157-63.

PMID:
24659658
11.

Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase.

Scrima M, De Marco C, Fabiani F, Franco R, Pirozzi G, Rocco G, Ravo M, Weisz A, Zoppoli P, Ceccarelli M, Botti G, Malanga D, Viglietto G.

PLoS One. 2012;7(2):e30427. doi: 10.1371/journal.pone.0030427. Epub 2012 Feb 17.

12.

Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer.

Chen ZL, Zhao SH, Wang Z, Qiu B, Li BZ, Zhou F, Tan XG, He J.

Chin J Cancer. 2011 Jan;30(1):62-8.

14.

Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: a retrospective analysis.

Xu YJ, Shao YF, Zhao X, Geng YT, Wang K, Yin YM.

J Cancer Res Clin Oncol. 2011 Dec;137(12):1841-8. doi: 10.1007/s00432-011-1054-5. Epub 2011 Sep 17.

PMID:
21927908
15.

High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.

Tang HR, Luo XQ, Xu G, Wang Y, Feng ZJ, Xu H, Shi YW, Zhang Q, Wu LG, Xue CQ, Wang CW, Wu CY.

World J Gastroenterol. 2012 Dec 28;18(48):7319-26. doi: 10.3748/wjg.v18.i48.7319.

16.

[Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].

Zhang Y, Liu YP, Du K, Wang H, Wang XL.

Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):594-8. Chinese.

PMID:
22325219
17.

Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.

Miao Y, Li AL, Wang L, Fan CF, Zhang XP, Xu HT, Yang LH, Liu Y, Wang EH.

Pathol Oncol Res. 2013 Apr;19(2):281-6. doi: 10.1007/s12253-012-9580-2. Epub 2012 Oct 20.

PMID:
23086683
18.

Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma.

Sun PL, Jin Y, Kim H, Seo AN, Jheon S, Lee CT, Chung JH.

Virchows Arch. 2013 Sep;463(3):427-36. doi: 10.1007/s00428-013-1462-9. Epub 2013 Aug 2.

PMID:
23907568
19.
20.

Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.

Luo Z, Wu RR, Lv L, Li P, Zhang LY, Hao QL, Li W.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):3632-46. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk